Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

2014 ACR/ARHP Annual Meeting: Bone Fracture Concerns in Children

Susan Bernstein  |  Issue: April 2015  |  April 1, 2015

“Pubertal delay is an important factor in peak bone mass. The later the onset of puberty, the lower your peak bone mass,” said Dr. Burnham. Glucocorticoid therapy may also reduce their sex steroids, muscle mass and calcium absorption, all contributing to lower bone mass. In these chronically ill patients, osteoclast development increases under the influence of RANK ligand, increasing bone resorption. They may have less osteoblast formation and lower bone formation, he said. “All of these factors converge to create lower bone mass and increased risk of fracture during childhood.” After skeletal maturation, when bone mass begins to decline, adult patients with a history of rheumatic disease during childhood may “reach the fracture threshold earlier than a person with relative health would,” Dr. Burnham said.

Dual-energy X-ray absorptiometry (DEXA) imaging helps rheumatologists assess bone mineral content and areal bone mineral density (BMD). Consider DEXA testing after a patient has taken six to 12 months of glucocorticoids, Dr. Burnham said.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Scores are strongly correlated with the patient’s height, Dr. Burnham said. “Patients with short stature will have a lower area BMD, even if their bones have normal volumetric density.” DEXA Z-scores may be adjusted at least for sex and age, and ideally, for race or other factors that may affect bone density. Z-score calculations that mitigate height bias can now be calculated on the Bone Mineral Density in Childhood Study website (http://www.bmdcspublic.com), he said.

A diagnosis of osteoporosis in a pediatric patient should not be made on the basis of densitometric criteria alone, Dr. Burnham said. A patient should have experienced one or more vertebral compression fractures in the absence of local disease or trauma. Alternatively, a patient should have two or more long bone fractures by age 10, three or more long bone fractures at any age up to 19, or a BMC or a BMD Z-score of less than or equal to -2.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

JIA patients face unique risks, he said. “Kids with JIA will all have the same bone risk factors as healthy kids,” including age, gender, nutritional status, intrauterine environment, genetic load, geography and risk-taking behaviors. “But JIA results in impaired cortical and trabecular bone accrual,” possibly due to medications, disease activity and lower muscle mass. They may be at greater risk for falls because of altered balance or muscle weakness, and face higher fracture risks in their arms and legs. If they have one fracture, they have an increased risk of another fracture later on, said Dr. Burnham.

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsMeeting ReportsOsteoarthritis and Bone DisordersPediatric Conditions Tagged with:ACR/ARHP Annual MeetingBernsteinChildrenFracturesglucocorticoidGlucocorticoid-Induced OsteoporosisOsteoporosispatient carePediatricRheumatic Diseasetherapy

Related Articles

    Case Report: Rheumatoid Arthritis Complicated by Large Granular Lymphocytic Leukemia

    November 14, 2021

    Large granular lymphocytic (LGL) leukemia is a rare, chronic, lymphoproliferative disorder of cytotoxic T cell or natural killer cell lineage with an annual incidence of 0.72 cases per 1 million people in the U.S.1 The most common sub­type of LGL leukemia, T-LGL leukemia, follows an indolent disease course and accounts for approximately 85% of cases….

    Osteoporosis Experts Discuss Bisphosphonate Holidays

    November 24, 2020

    ACR CONVERGENCE 2020—Bisphosphonates are an important treatment for millions of older Americans with osteoporosis because the drugs inhibit osteoclastic bone resorption to reduce the risk of painful, debilitating fractures.1 More than 20 years ago, data emerged that bisphosphonates have a long terminal half-life.2 So after years of therapy, could some patients take a drug holiday?…

    Unexpected Benefits of Bisphosphonates after Hip Fracture

    February 3, 2012

    Recent trials show this bisphosphonates can reduce subsequent hip fractures and mortality, while remaining cost effective.

    Build Up Bone

    June 1, 2007

    Current management of osteoporosis

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences